Reneo Pharmaceuticals Banner Image

Reneo Pharmaceuticals

  • Ticker RPHM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Reneo Pharmaceuticals Logo Image
  • 11-50 Employees
  • Based in Irvine, California
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Their goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondriaMore work, preserving muscle function and preventing muscle injury, weakness and wasting. They are currently advancing a novel molecule into several diseases. Their experienced team of drug development experts, who have collaborated in many successful programs, are dedicated and passionate about finding effective therapies for these complex rare diseases.
Reneo Pharmaceuticals

Most Recent Annual Report

Reneo Pharmaceuticals
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Reneo Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!